1. Home
  2. EEIQ vs SNGX Comparison

EEIQ vs SNGX Comparison

Compare EEIQ & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EEIQ
  • SNGX
  • Stock Information
  • Founded
  • EEIQ 2017
  • SNGX 1987
  • Country
  • EEIQ United States
  • SNGX United States
  • Employees
  • EEIQ N/A
  • SNGX N/A
  • Industry
  • EEIQ Other Consumer Services
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EEIQ Real Estate
  • SNGX Health Care
  • Exchange
  • EEIQ Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • EEIQ 12.1M
  • SNGX 10.1M
  • IPO Year
  • EEIQ 2021
  • SNGX 1987
  • Fundamental
  • Price
  • EEIQ $0.50
  • SNGX $2.92
  • Analyst Decision
  • EEIQ
  • SNGX Strong Buy
  • Analyst Count
  • EEIQ 0
  • SNGX 1
  • Target Price
  • EEIQ N/A
  • SNGX $6.00
  • AVG Volume (30 Days)
  • EEIQ 12.7M
  • SNGX 10.0M
  • Earning Date
  • EEIQ 08-21-2025
  • SNGX 11-07-2025
  • Dividend Yield
  • EEIQ N/A
  • SNGX N/A
  • EPS Growth
  • EEIQ N/A
  • SNGX N/A
  • EPS
  • EEIQ N/A
  • SNGX N/A
  • Revenue
  • EEIQ $9,358,301.00
  • SNGX N/A
  • Revenue This Year
  • EEIQ N/A
  • SNGX N/A
  • Revenue Next Year
  • EEIQ N/A
  • SNGX N/A
  • P/E Ratio
  • EEIQ N/A
  • SNGX N/A
  • Revenue Growth
  • EEIQ 44.99
  • SNGX N/A
  • 52 Week Low
  • EEIQ $0.42
  • SNGX $1.09
  • 52 Week High
  • EEIQ $1.74
  • SNGX $6.23
  • Technical
  • Relative Strength Index (RSI)
  • EEIQ 45.84
  • SNGX 51.64
  • Support Level
  • EEIQ $0.48
  • SNGX $2.58
  • Resistance Level
  • EEIQ $0.56
  • SNGX $3.11
  • Average True Range (ATR)
  • EEIQ 0.09
  • SNGX 0.22
  • MACD
  • EEIQ -0.01
  • SNGX -0.09
  • Stochastic Oscillator
  • EEIQ 5.45
  • SNGX 43.59

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: